Day: August 5, 2022

Net Profit of 15.8 Million Euro (+6% Y/Y), Bringing the Net Result for the First Half Year to 31.5 Million Euro (+15% vs 1H21)Earnings Driven by Growth in Revenue, Which Rose to 80.6 Million Euro in 2Q22 (+13% Y/Y), illimity’s Best Quarterly Figure, and to 159 Million Euro in 1H22 (+25% Y/Y)Net Customer Loans at 3.2 Billion Euro (+37% Y/Y)Excellent Asset Quality and Capital Base:Organic NPE Ratio1 of 0.9% and CET1 Ratio of Over 17%2Purchase of Arec Finalised at the End of the Quarter,Positioning Neprix as the Third Operator Specialising in the Management of Corporate UTP Loans3Positive Earnings Prospects Thanks to a Vigorous Business Pipelinefor the Coming Months MILAN, Italy, Aug. 05, 2022 (GLOBE NEWSWIRE) — via InvestorWire — Chaired by Rosalba Casiraghi, the Board of Directors of illimity Bank S.p.A. (“illimity” or the...

Net Profit of 15.8 Million Euro (+6% Y/Y), Bringing the Net Result for the First Half Year to 31.5 Million Euro (+15% vs 1H21)Earnings Driven by Growth in Revenue, Which Rose to 80.6 Million Euro in 2Q22 (+13% Y/Y), illimity’s Best Quarterly Figure, and to 159 Million Euro in 1H22 (+25% Y/Y)Net Customer Loans at 3.2 Billion Euro (+37% Y/Y)Excellent Asset Quality and Capital Base:Organic NPE Ratio1 of 0.9% and CET1 Ratio of Over 17%2Purchase of Arec Finalised at the End of the Quarter, Positioning Neprix as the Third Operator Specialising in the Management of Corporate UTP Loans3Positive Earnings Prospects Thanks to a Vigorous Business Pipeline for the Coming Months MILAN, Italy, Aug. 05, 2022 (GLOBE NEWSWIRE) — via InvestorWire — Chaired by Rosalba Casiraghi, the Board of Directors of illimity Bank S.p.A. (“illimity” or the...

Conference Call and Webcast Today at 8:30 a.m. ETDosing patients in U.S. Phase 2/3 COVAXIN™ (BBV152) clinical trial Completed dosing of patients in Cohort 1 of OCU400 gene therapy product candidate Expanding product pipeline with the regenerative medicine cell therapy program NeoCart®MALVERN, Pa., Aug. 05, 2022 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines, today reported financial results for the quarter ended June 30, 2022, and provided a general business update. “The second quarter was marked by several important milestones,” said Dr. Shankar Musunuri, Chairman, Chief Executive Officer, and Co-Founder of Ocugen. “On the vaccine front, we continued to work diligently with our...

DALLAS, Aug. 05, 2022 (GLOBE NEWSWIRE) — CSW Industrials, Inc. (Nasdaq: CSWI or the “Company”) today reported results for the fiscal 2023 first quarter ended June 30, 2022. Fiscal 2023 First Quarter Highlights (comparisons to fiscal 2022 first quarter)Total revenue increased 24% to $199.9 million, compared to $161.3 million Organic revenue increased $30.1 million, representing 78% of total revenue growth, with all three segments reporting record historic quarterly revenue GAAP net income attributable to CSWI improved to $29.4 million, compared to the prior year period of $20.5 million, or $23.4 million as adjusted to exclude the final TRUaire purchase accounting effect EBITDA growth of 21% to $49.5 million, compared to $40.9 million Earnings per diluted share increased to $1.88, compared to the prior year period of...

Raises 2022 revenue guidance and improves 2022 Adjusted EBITDA guidance BOSTON, Aug. 05, 2022 (GLOBE NEWSWIRE) — DraftKings Inc. (Nasdaq: DKNG) (“DraftKings” or the “Company”) today reported its second quarter 2022 financial results. Second Quarter 2022 Highlights For the three months ended June 30, 2022, DraftKings reported revenue of $466 million, an increase of 57% compared to $298 million during the same period in 2021. Revenue for the Company’s B2C segment grew to $455 million, an increase of 68% compared to the three months ended June 30, 2021, notwithstanding a less favorable sports calendar in the second quarter of 2022 compared to the second quarter of 2021. Revenue and Adjusted EBITDA outperformed the midpoints of their respective guidance ranges for the second quarter of 2022, which were previously provided by DraftKings...

Record third quarter sales of $673.6 million, an increase of 12.9% from the prior year period; Comparable sales growth of 7.4% Net income increase of 3.5% from the prior year period to $123.0 million; Adjusted net income increase of 1.1% from the prior year period to $125.7 million Diluted earnings per share of $0.67 compared to $0.61 in the prior year period and Adjusted diluted earnings per share of $0.68 compared to $0.64 in the prior year period Adjusted EBITDA increase of 2.0% from the prior year period to $182.9 million Revises Fiscal 2022 outlook for sales to increase 15% to 17%, Adjusted EBITDA to increase 6% to 10%, and Adjusted earnings per share to increase 6% to 13% compared to Fiscal 2021PHOENIX, Aug. 05, 2022 (GLOBE NEWSWIRE) — Leslie’s, Inc. (“Leslie’s”, “we”, “our” or “its”; NASDAQ: LESL), the largest...

BANNOCKBURN, Ill., Aug. 05, 2022 (GLOBE NEWSWIRE) — Stericycle, Inc. (Nasdaq: SRCL) today reported results for the second quarter ended June 30, 2022. Revenues for the second quarter were $679.8 million, an increase of 1.1% compared to $672.7 million in the second quarter of 2021, with organic revenues1 growing 5.0%. Income from operations was $38.1 million compared to $55.6 million in the second quarter of 2021. Net income was $10.5 million, or $0.11 diluted earnings per share, compared to net income of $29.3 million, or $0.32 diluted earnings per share, in the second quarter of 2021. Adjusted income from operations1 was $82.0 million, compared to $105.7 million in the second quarter of 2021. Adjusted diluted earnings per share1 was $0.48, compared to $0.67 in the second quarter of last year. Cash flow from operations for the...

NEW YORK, Aug. 05, 2022 (GLOBE NEWSWIRE) — AMC Networks Inc. (“AMC Networks” or the “Company”) (NASDAQ: AMCX) today reported financial results for the second quarter ended June 30, 2022. Interim Chief Executive Officer Matt Blank said: “AMC Networks delivered a solid second quarter, benefiting from strong subscriber growth for our differentiated streaming services as we execute on our strategy to super-serve passionate audiences with a curated, targeted content experience. We added nearly 1.3 million new subscribers in aggregate across our streaming portfolio, ahead of our forecast, to end the quarter with 10.8 million total paying subscribers. As we leverage our strong linear business, we are seeing increasing demand for our digital and advanced advertising opportunities. And our content creation strengths were on full display...

TORONTO and HOUSTON, Aug. 05, 2022 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or “the Company”) (NASDAQ: MDNA TSX: MDNA), a clinical stage immuno-oncology company, today announced that it will host a conference call and live webcast on August 15, 2022 at 8:30 AM ET to report its first quarter fiscal 2023 financial results and operational highlights. To access the call, please dial 1-877-407-9716 from Canada or the United States or 1-201-493-6779 internationally, followed by the conference ID: 13731985. To access the live webcast, please go visit https://viavid.webcasts.com/starthere.jsp?ei=1560574&tp_key=dc821e35e8. Following the live webcast, an archived version of the call will be available on Medicenna’s website. About MedicennaMedicenna is a clinical stage immunotherapy company focused...

Delivers 46% top-line growth driven by increases in Digital and Synchronization revenues, as well as strength in Performance revenues Reaffirms full fiscal year revenue and profitability guidance NEW YORK, Aug. 05, 2022 (GLOBE NEWSWIRE) — Reservoir Media, Inc. (NASDAQ: RSVR) (“Reservoir” or the “Company”), an award-winning independent music company, today announced financial results for the first fiscal quarter of 2023 ended June 30, 2022. Recent Highlights:Revenue of $24.3 million, increased 14% organically, or 46% including acquisitions year-over-yearMusic Publishing revenue rose 35% year-over-year Recorded Music revenue increased by 80% year-over-yearOperating Income of $1.3 million, increased by $1.1 million year-over-year OIBDA (“Operating Income Before Depreciation & Amortization”) of $6.7 million, an increase...